A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane

Author： Suzuki Yasuhiro   Saeki Toshiaki   Aogi Kenjiro   Toi Masakazu   Fujii Hirofumi   Inoue Kenichi   Watanabe Toru   Fujiwara Yasuhiro   Ito Yoshinori   Takatsuka Yuichi   Iwata Hiroji   Arioka Hitoshi   Tokuda Yutaka  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.4, 2013-08, pp. : 590-597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

By Smorenburg C.H.   Bontenbal M.   Seynaeve C.   Zuylen C.v.   Heus G.d.   Verweij J.   Wit R.d.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 83-87

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Gemcitabine Plus Paclitaxel in Metastatic Breast Cancer Patients with Prior Anthracycline Exposure

By Demiray Mutlu   Kurt Ender   Evrensel Turkkan   Kanat Ozkan   Arslan Murat   Saraydaroglu Ozlem   Ercan Ilker   Gonullu Guzin   Gokgoz Sehsuvar   Topal Ugur   Tolunay Sahsine   Tasdelen Ismet   Manavoglu Osman  

Cancer Investigation, Vol. 23, Iss. 5, 2005-07 ,pp. : 386-391

Informa Healthcare

Access to resources Recommend Favorite

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

By Minckwitz Gunter   Jonat Walter   Fasching Peter   Bois Andreas   Kleeberg Ulrich   Lück Hans-Joachim   Kettner Erika   Hilfrich Jörn   Eiermann Wolfgang   Torode Julie   Schneeweiss Andreas  

Breast Cancer Research and Treatment, Vol. 89, Iss. 2, 2005-01 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

By Clemons Mark   Joy Anil   Abdulnabi Radhi   Kotliar Mauricio   Lynch Jodi   Jordaan Johan   Iscoe Neill   Gelmon Karen  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer

By Seo Jae   Oh Sang   Choi Cheul   Kim Byung   Shin Sang   Kim Yeul   Kim Jun   Kim Ae-Ree   Lee Jae-Bok   Koo Bum  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 2, 2007-02 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite